February 4th 2025
A report offers a comprehensive benchmarking and assessment of pharmaceutical manufacturer engagement with specialty pharmacies.
January 20th 2025
Despite challenges surrounding communication overload, drug shortages, and cybersecurity risks, this term is revolutionizing medication management and patient care through the use artificial intelligence and predictive forecasting.
January 3rd 2025
A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today.
December 23rd 2024
How will supply chains in the space continue to develop?
November 26th 2024
Why well-organized documentation is critical at every stage of the process.
DME competitive bidding issues: When is enough enough?
Retailers, distributors and manufacturers are being affected by federal rules on durable medical equipment (DME)
The best 'good guys' in pharma distribution
Recent US Supreme Court decisions narrow life-sciences patentability claims
Industry response may be to keep more innovations as trade secrets
Getting to the 'hub' of the matter
The perfect pharmaceutical product would be a pill or injection that, once taken, has a near-immediate beneficial effect.
Supreme Court: reverse payment settlements subject to antitrust scrutiny
What are the risks of future 'pay for delay' settlements between branded and generic manufacturers?
Worldwide, pharma distribution is moving to a serial-coded basis
Regardless of how pending US legislation is resolved, manufacturers need to move ahead
Medical Affairs' changing role in market access and reimbursement
Outsourced facilities management saves precious financial resources
Life sciences companies - including mid-market ones - are finding value in an outsourced service
How about a US Chamber of Healthcare Commerce?
The full range of healthcare manufacturers should have a unified voice
test
The downside of pricing specialty pharmaceuticals too high
Why 'recall readiness' should be top-of-mind for every pharma exec
Should personalized medicine imply compromised patient safety?
Continuing problems with compounding pharmacies muddle biopharma’s future direction
Why community oncology matters
Oncology is the market for today's pipeline products. Here's why the community setting needs to be preserved as a primary site of care to administer those products
Managing the specialty pharmacy channel's evolution
Focusing pharma marketing on 'headroom'
In the race to improve product performance, not enough attention is paid to 'who's actually going to switch?'
The war on prescription drug abuse
Like the other war on drugs, there's no end in sight
Pharma's stake in comparative effectiveness research
When drugs in development today hit the marketplace in 2020, they will need evidence of economic and clinical value results to be commercially successful
Liberating time in the Economy of Attention
Pharmaceutical marketing is now operating in a new landscape--the Economy of Attention
Tomorrow's biopharma industry: new biotech products or higher operational efficiency--or both?
Abbott's spinout of AbbVie offers lessons
Another go at medication adherence
A managed services approach to sales and marketing
Applying the managed services model to commercial operations can result in dramatic savings as pharma companies globalize
BeSafeRx: FDA helping consumers avoid risks of online prescription drug purchases
Complex supply chains demand a holistic approach to protect patients
The USP standard, currently in draft form, is an effort to provide recommendations for end-to-end supply chain integrity
In the evolving world of pharma compliance, The PDMA Sharing Conference provides answers
Tectonic shifts in the product-security debate
Industry is not waiting for action in Washington
The clear and present danger of counterfeit drugs
Prospects for international policing of counterfeit drugs is dim
Packaging, serialization and medication adherence: the coming connection
Modernized packaging technologies can change the drug-distribution dynamic - and improve overall healthcare
Innovative collaboration could address today's drug shortages productively
Supply chains for a patient-centric world
Tomorrow's healthcare market, driven by consumer choice and outcomes-driven economics, will create new supply chain models